Best of the blog is a monthly column highlighting the best of our free online content at www.windhover.com/blog. In February, Windhover's editorial staff posted 26 articles to the site, covering biopharma R&D, business development, regulatory, and commercial news. Highlights included informed musings on the likelihood of health care reform, comparative effectiveness, and regulatory misfires at drug companies. Here we've excerpted a few of our favorite blog posts, which are not covered elsewhere in this month's IN VIVO.
(February 8.) The Agency for Health Care Research & Quality (the US government's de facto comparative effectiveness research center) is...